Skip to content

Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography

Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02028299
Enrollment
38
Registered
2014-01-07
Start date
2010-04-30
Completion date
2012-07-31
Last updated
2014-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Arterial Hypertension

Keywords

Pulmonary Arterial Hypertension, Pulmonary Vascular Resistance, Right Heart Catheterization

Brief summary

An echocardiogram using Definity contrast can provide the same information as the standard right heart catheterization.

Interventions

PROCEDURE2D doppler echo with Definity solution

Correlate right heart catheterization results with results from 2D doppler echo with Definity Solution

Sponsors

George Washington University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients scheduled to undergo right heart catheterization at the George Washington University Hospital

Exclusion criteria

* Patients with known or suspected right-to-left bi-directional or transient right-to-left shunts or pulmonary arteriovenous malformations, previously documented moderate to severe tricuspid regurgitation or moderate to severe pulmonary regurgitation, evidence of right ventricular hypokinesis, or prior adverse reaction to Definity or hypersensitivity to perflutren

Design outcomes

Primary

MeasureTime frameDescription
Measure Pulmonary Vascular Resistance using 2D Doppler Echocardiogram w/Definity SolutionTwo YearsCorrelation coefficients between the technique above the the gold standard right heart catheterization measures of pulmonary vascular resistance.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026